Description:

This trial seeks to determine the effect of androgen deprivation therapy with or without docetaxel on overall survival in prostate cancer patients with EXTENSIVE metastatic disease (visceral lesions or 4+ bony metastases) and who have been on androgen deprivation therapy for less than 90 days.

Link:

http://clinicaltrials.gov/ct2/show/NCT00309985

Site:

Johns Hopkins Hospital

Principal investigator:

Michael Carducci, M.D.